Oragenics Announces ONP-002 Completed A Study Indicating It Does Not Cause DNA Damage And Genotoxicity In An Animal Model
Portfolio Pulse from Benzinga Newsdesk
Oragenics announced that its product ONP-002 has completed a study indicating it does not cause DNA damage and genotoxicity in an animal model.
August 12, 2024 | 12:33 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oragenics' ONP-002 has completed a study showing it does not cause DNA damage or genotoxicity in an animal model, which is positive news for the company's product pipeline.
The study results are a significant milestone for Oragenics, as they indicate the safety of ONP-002, potentially increasing investor confidence and positively impacting the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100